Word

SATIO

Status

Pending

Status Code

688

Status Date

Tuesday, October 31, 2023

Serial Number

97512123

Mark Type

4000

Filing Date

Wednesday, July 20, 2022

Published for Opposition

Tuesday, September 5, 2023

Trademark Owner History

Satio, Inc. - Owner At Publication

Classifications

5 Vaccines, namely, dermal patches featuring vaccines; pharmaceutical preparations for the prevention and treatment of infectious diseases and non-infectious diseases, namely, dermal patches featuring pharmaceutical preparations for the prevention and treatment of hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; medical diagnostic reagents and assays for testing of body fluids, namely, dermal patches featuring medical diagnostics or assays for testing of body fluids; reagents for use in medical genetic testing, namely, dermal patches featuring reagents for use in medical genetic testing

10 Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; genetic testing apparatus for medical purposes; dermal patches for delivery of pharmaceuticals and vaccines, sold empty; medical devices for obtaining body fluid samples; medical devices for testing body fluid samples; dermal patches for testing DNA and RNA samples; dermal patches for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, , immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; dermal patches for testing for genetic testing; dermal patches for obtaining body fluid samples; dermal patches for testing body fluid samples

Trademark Events

Nov 30, 2023

Corrected Noa E-Mailed

Nov 29, 2023

Notice Of Allowance Correction Entered

Nov 9, 2023

Case Assigned To Intent To Use Paralegal

Oct 24, 2023

Teas Post Publication Amendment Received

Oct 31, 2023

Noa E-Mailed - Sou Required From Applicant

Sep 5, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2023

Published For Opposition

Aug 16, 2023

Notification Of Notice Of Publication E-Mailed

Jul 29, 2023

Approved For Pub - Principal Register

Jul 28, 2023

Teas/Email Correspondence Entered

Jul 27, 2023

Correspondence Received In Law Office

Jul 27, 2023

Teas Response To Office Action Received

May 18, 2023

Notification Of Priority Action E-Mailed

May 18, 2023

Priority Action E-Mailed

May 18, 2023

Priority Action Written

May 17, 2023

Notification Of Priority Action E-Mailed

May 17, 2023

Priority Action E-Mailed

May 17, 2023

Priority Action Written

May 5, 2023

Assigned To Examiner

Aug 10, 2022

New Application Office Supplied Data Entered

Jul 23, 2022

New Application Entered